
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: November 9th 2017 | Updated:

Published: January 13th 2018 | Updated: